Description
Semaglutide is a modified peptide analogue of glucagon-like peptide-1 (GLP-1). Its structure contains a linear sequence of 31 amino-acid residues together with a fatty-acid-containing side chain. It belongs to both the polypeptide and lipopeptide structural classes.
Relative to the parent GLP-1 sequence, semaglutide includes selected amino-acid substitutions. These include alpha-aminoisobutyric acid at position 8 and arginine at position 34, using the parent GLP-1 numbering convention.
A C18 fatty diacid-containing group is attached through a spacer to lysine at position 26. The spacer, lipid-containing side chain and peptide backbone together form the complete molecular structure; they are not separate blend ingredients.
The original scientific context identifies semaglutide as a GLP-1-receptor agonist and discusses its relationship to endogenous GLP-1. That classification describes a biochemical receptor target, while the modified sequence and attached side chain distinguish semaglutide from the unmodified parent peptide.
Chemical Makeup
- Molecular formula: C187H291N45O59
- Peptide length: 31 amino acids
- Structural class: Polypeptide and lipopeptide
For Research Purposes Only





















Reviews
There are no reviews yet.